Abstract：ObjectiveTo investigate the clinical effect of low molecular weight heparin for fetal growth restriction pregnant women and perinatal outcome.Methods96 cases of FGR pregnant women in our hospital from November 2015 to July 2016 were randomly divided into research group and control group,48 cases in each group.The control group was treated with maternal underlying diseases,early strengthening of diet nutrition,while the research group was treated with low molecular weight heparin based on the treatment control group.The height of the uterus and fetal growth,amniotic fluid index,and biophysical score of pregnant women,and gestational age,weight and asphyxia of newborn,platelet count and coagulation function index changes of two groups were compared.ResultsAfter treatment,the height of the uterus, the growth value of head circumference,abdominal circumference,biparietal diameter and femur length of research group newborns were higher than those of control group(P＜0.05).The amniotic fluid index,and biophysical score of research group were(13.79±1.46)cm,(9.93±0.58)points respectively,which were better than those of control group of(11.41±1.50)cm, (9.26±0.42)points(P＜0.05).The newborns gestational age,weight of research group were better than those of control group (P＜0.05).Newborns asphyxia rate of research group was lower than that of control group(P＜0.05).The platelet count and coagulation function index of two groups had no significant difference(P＞0.05).ConclusionLow molecular weight heparin has exact effect for FGR.The weight of newborn is improved,and low molecular weight heparin could improve placental blood circulation,promote fetal growth,reduce the incidence of neonatal asphyxia.It′s worthy of wildly used.
京公网安备 11010502046607号